Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on peginterferon alfa in virally suppressed chronic hepatitis B on nucleos(t)ide analogue therapy
ACTRN12615000915550Phase 2Not yet recruiting
- Sponsor
- Peter Angus
- Start
- Sep 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated interferon alpha, entecavir, tenofovir, sponsored by Peter Angus. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
pegylated interferon alphaentecavirtenofovir
Beyond the preview
Go deeper on ACTRN12615000915550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000915550.